Zofran (Ondasetron): Difference between revisions
Jump to navigation
Jump to search
Danesthesia (talk | contribs) No edit summary |
Danesthesia (talk | contribs) No edit summary |
||
| Line 6: | Line 6: | ||
{{Infobox|anestheticplana=fsdg|anestheticplanb=sgdf|position=sfg|length=sdfg|ebl=sdfg|postoppainlevel=sdfg}} | {{Infobox|anestheticplana=fsdg|anestheticplanb=sgdf|position=sfg|length=sdfg|ebl=sdfg|postoppainlevel=sdfg}} | ||
asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf | |||
==Route of administration== | ==Route of administration== | ||
*Oral: Disintegrating tablets, film-coated tablets, and oral solution | *Oral: Disintegrating tablets, film-coated tablets, and oral solution | ||
Revision as of 09:02, 16 May 2023
Zofran (Ondasetron)
| drug name: | drugggg |
|---|---|
| width: | 99 |
| alt: | sdfasdf |
Zofran (Ondasetron)
| Anesthetic Plan A: | fsdg |
|---|---|
| Anesthetic Plan B: | sgdf |
| Position | sfg |
| Length: | sdfg |
| Estimated Blood Loss: | sdfg |
| Post-op Pain Level: | sdfg |
asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf asdfasfdasdfas asfsadf
Route of administration
- Oral: Disintegrating tablets, film-coated tablets, and oral solution
- Intravenous: Injection
- Intramuscular: Injection
Dose
For anesthesia-related nausea and vomiting:
- Adult:
* Oral: 16 mg before anesthesia induction * Intravenous: 4 mg before anesthesia induction or immediately before/during/after surgery
- Pediatric:
* Oral: 4 mg for children aged 4-11 years, 30-60 minutes before surgery * Intravenous: 0.1 mg/kg (up to 4 mg) for children aged 1 month-12 years, immediately before/during/after surgery
Half-life
- The elimination half-life of ondansetron is approximately 3-6 hours.
Expected time to work
- Oral: Onset of action is approximately 30 minutes to 2 hours.
- Intravenous: Onset of action is approximately 5-30 minutes.
Use in anesthesia
Zofran is commonly used in anesthesia to:
- Prevent postoperative nausea and vomiting (PONV)
- Prevent nausea and vomiting induced by chemotherapy
- Prevent nausea and vomiting associated with radiation therapy
Side effects
- Headache
- Fatigue
- Constipation
- Diarrhea
- Dizziness
Contraindications
- Hypersensitivity to ondansetron or any component of the formulation
- Concomitant use with apomorphine
- Patients with congenital long QT syndrome
Drug interactions
- Serotonin syndrome risk may increase when combined with other serotonergic agents (e.g., SSRIs, SNRIs, TCAs, MAOIs, triptans)
References